Sort
15,842 grants matching “pancreatic cancer”
Novel Cell Cycle Therapeutic Targets in Pancreatic Cancer
$202,275Steven F Dowdy · University Of California, San Diego · R21 · FY2013 · CA
N-cadherin and Metastatic Dissemination
$202,275Glenn Lawrence Radice · Thomas Jefferson University · R21 · FY2015 · CA
PET imaging of the tumor microenvironment for cancer detection
$202,275Thaddeus J Wadas · Wake Forest University Health Sciences · R21 · FY2018 · CA
Utilizing HuR to optimize the treatment of pancreatic cancer
$202,275Jonathan Brody · Thomas Jefferson University · R21 · FY2014 · CA
GPCRs: novel targets in cancer-associated fibroblasts
$202,275Paul A Insel · University Of California, San Diego · R21 · FY2014 · CA
Targeting PHD2 in Pancreatic Cancer
$202,275Haiyong Han · Translational Genomics Research Inst · R21 · FY2015 · CA
Biological and Therapeutic Significance of TG2 in Pancreatic Cancer
$202,241Kapil Mehta · University Of Tx Md Anderson Can Ctr · R21 · FY2010 · CA
Multimodal Federated Learning for Pan-Cancer Detection of Cachexia and Early Detection of Pancreatic Cancer
$202,200John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2024 · CA
Screening Markers for Persons with High Pancreatic Cancer Susceptibility
$202,198Michael G. Goggins · Johns Hopkins University · P50 · FY2009 · CA
Optical Spectroscopy for Minimally Invasive Pancreatic Cancer Risk-stratification
$202,060Vadim Backman · Northwestern University · R21 · FY2006 · EB
Outreach Core
$201,966Lourdes Baezconde Garbanati · University Of Southern California · U54 · FY2023 · CA
Core C â Immunophenotyping Core
$201,964Martin John Romeo · Medical University Of South Carolina · P01 · FY2021 · CA
Mutant p53 gain-of-function as an actionable target in cancer therapy
$201,940Alice Nemajerova · State University New York Stony Brook · R50 · FY2023 · CA
Mutant p53 gain-of-function as an actionable target in cancer therapy
$201,940Alice Nemajerova · State University New York Stony Brook · R50 · FY2024 · CA
Theranostic Metabolic Imaging of Oxidative Stress in Multiple Sclerosis.
$201,875Myriam Marianne Chaumeil · University Of California, San Francisco · R21 · FY2024 · AI
Molecular Pathomechanism of Hereditary Pancreatitis
$201,875Boston University Medical Campus · R01 · FY2003 · DK
Molecular Imaging of CD46
$201,875Kondapa Naidu Bobba · University Of California, San Francisco · R21 · FY2022 · EB
Therapy of pancreatic cancer with 212Pb-labeled B7-H3 specific Ab and LDE225
$201,799Donald J Buchsbaum · University Of Alabama At Birmingham · R21 · FY2015 · CA
Enhancement of Tumor-Targeted Transgene Expression
$201,742Synergene Therapeutics, Inc. · R41 · FY2004 · CA
Research Training in Alimentary Tract Surgery
$201,730David I Soybel · Brigham And Women'S Hospital · T32 · FY2007 · DK
Targeted nanotechnology for the pancreatic tumor immune microenvironment
$201,715Martin G Pomper · Ut Southwestern Medical Center · P41 · FY2025 · EB
MOB-5 IN COLORECTAL &PANCREATIC CANCER
$201,636Vanderbilt University · R01 · FY2000 · CA
Nuclear receptor LRH-1 in pancreatic cancer
$201,623Robert J Fletterick · University Of California, San Francisco · R21 · FY2010 · CA
Needle biopsy preservation and preparation for rapid 3D pathology of pancreas
$201,623Eric J Seibel · University Of Washington · R21 · FY2015 · CA
CORE--PANCREAS TUMOR SPORE TISSUE BANK
$201,603University Of Nebraska Medical Center · P50 · FY2000 · CA